Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt

David Romano1, David Matallanas, Gregory Weitsman

  • 1Proteomics and Signalling Networks Group, The Beatson Institute for Cancer Research, London, United Kingdom.

Cancer Research
|January 21, 2010
PubMed

Insights

Mammalian sterile 20 kinase 2 (MST2) activity is controlled by Akt phosphorylation, which inhibits its tumor-suppressive apoptosis function. This study reveals how Akt integrates signals from Raf-1 and RASSF1A pathways to regulate MST2.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Biology

Background:

  • Mammalian sterile 20 kinase 2 (MST2) is crucial for stress-induced apoptosis, limiting tumor progression.
  • Regulation of MST2 by cell division and survival pathways, particularly its interaction with Raf-1 and RASSF1A, is not fully understood.
  • Akt kinase is known to phosphorylate MST2 in response to mitogenic and oncogenic stimuli.

Purpose of the Study:

  • To elucidate the regulatory mechanisms controlling MST2 activity by key signaling pathways.
  • To identify specific Akt phosphorylation sites on MST2 and their functional consequences.
  • To understand how MST2 integrates signals from Raf-1 and Akt pathways in cell division and survival.

Main Methods:

  • Identification and mutation of Akt phosphorylation sites (T117 and T384) in MST2.
  • Analysis of MST2 binding interactions with Raf-1 and RASSF1A.
  • Assessment of downstream signaling pathways, including c-Jun NH(2)-terminal kinase and p38 mitogen-activated protein kinase.
  • Investigation of MST2 homodimerization and its role in activation.

Main Results:

  • Akt phosphorylates MST2 at T117 and T384, inhibiting its binding to RASSF1A and promoting association with Raf-1.
  • Mutations at these sites enhance MST2 binding to RASSF1A, increase downstream signaling, and promote apoptosis.
  • Akt-mediated MST2 phosphorylation prevents MST2 homodimerization and its activation, while dissociation from Raf-1 promotes mitogenic signaling.

Conclusions:

  • MST2 acts as a critical hub integrating signals from Raf-1 and Akt pathways.
  • Akt phosphorylation of MST2 serves as a key inhibitory mechanism, balancing cell survival and apoptosis.
  • Understanding MST2 regulation provides insights into tumor progression and potential therapeutic strategies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...